AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
3min chapter
320: Jim Wilson's next venture, a surprise startup shutdown, & Lilly's Zepbound strategy
The Readout Loud
Navigating Eli Lilly's Zepbound Pricing Strategy
This chapter analyzes Eli Lilly's recent rollout of discounted vials for its obesity drug, Zepbound, amidst a mixed reception from experts and the public. It also examines the implications of altered pricing strategies and transparency issues in marketing the medication.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode